These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 11752702)
1. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. Leroy EM; Baize S; Mavoungou E; Apetrei C J Gen Virol; 2002 Jan; 83(Pt 1):67-73. PubMed ID: 11752702 [TBL] [Abstract][Full Text] [Related]
2. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus. Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933 [TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak. Dietzel E; Schudt G; Krähling V; Matrosovich M; Becker S J Virol; 2017 Jan; 91(2):. PubMed ID: 27847361 [TBL] [Abstract][Full Text] [Related]
4. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Georges-Courbot MC; Sanchez A; Lu CY; Baize S; Leroy E; Lansout-Soukate J; Tévi-Bénissan C; Georges AJ; Trappier SG; Zaki SR; Swanepoel R; Leman PA; Rollin PE; Peters CJ; Nichol ST; Ksiazek TG Emerg Infect Dis; 1997; 3(1):59-62. PubMed ID: 9126445 [TBL] [Abstract][Full Text] [Related]
5. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098 [TBL] [Abstract][Full Text] [Related]
6. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells. Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536 [TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of the L protein of the Ebola 2014 outbreak: Insight into conserved regions and mutations. Ayub G; Waheed Y Mol Med Rep; 2016 Jun; 13(6):4821-6. PubMed ID: 27082438 [TBL] [Abstract][Full Text] [Related]
8. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. Prehaud C; Hellebrand E; Coudrier D; Volchkov VE; Volchkova VA; Feldmann H; Le Guenno B; Bouloy M J Gen Virol; 1998 Nov; 79 ( Pt 11)():2565-72. PubMed ID: 9820131 [TBL] [Abstract][Full Text] [Related]
9. Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda. Sanchez A; Rollin PE Virus Res; 2005 Oct; 113(1):16-25. PubMed ID: 16139097 [TBL] [Abstract][Full Text] [Related]
10. Emergence of subtype Zaire Ebola virus in Gabon. Volchkov V; Volchkova V; Eckel C; Klenk HD; Bouloy M; LeGuenno B; Feldmann H Virology; 1997 May; 232(1):139-44. PubMed ID: 9185597 [TBL] [Abstract][Full Text] [Related]
11. Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. Licata JM; Johnson RF; Han Z; Harty RN J Virol; 2004 Jul; 78(14):7344-51. PubMed ID: 15220407 [TBL] [Abstract][Full Text] [Related]
12. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. Rodriguez LL; De Roo A; Guimard Y; Trappier SG; Sanchez A; Bressler D; Williams AJ; Rowe AK; Bertolli J; Khan AS; Ksiazek TG; Peters CJ; Nichol ST J Infect Dis; 1999 Feb; 179 Suppl 1():S170-6. PubMed ID: 9988181 [TBL] [Abstract][Full Text] [Related]
13. Emergence of Zaire Ebola virus disease in Guinea. Baize S; Pannetier D; Oestereich L; Rieger T; Koivogui L; Magassouba N; Soropogui B; Sow MS; Keïta S; De Clerck H; Tiffany A; Dominguez G; Loua M; Traoré A; Kolié M; Malano ER; Heleze E; Bocquin A; Mély S; Raoul H; Caro V; Cadar D; Gabriel M; Pahlmann M; Tappe D; Schmidt-Chanasit J; Impouma B; Diallo AK; Formenty P; Van Herp M; Günther S N Engl J Med; 2014 Oct; 371(15):1418-25. PubMed ID: 24738640 [TBL] [Abstract][Full Text] [Related]
14. An evolutionary insight into emerging Ebolavirus strains isolated in Africa. Pereira-Gomez M; Lopez-Tort F; Fajardo A; Cristina J J Med Virol; 2020 Aug; 92(8):988-995. PubMed ID: 31702053 [TBL] [Abstract][Full Text] [Related]
15. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
16. Analysis of CD8 Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008 [TBL] [Abstract][Full Text] [Related]
17. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Leroy EM; Rouquet P; Formenty P; Souquière S; Kilbourne A; Froment JM; Bermejo M; Smit S; Karesh W; Swanepoel R; Zaki SR; Rollin PE Science; 2004 Jan; 303(5656):387-90. PubMed ID: 14726594 [TBL] [Abstract][Full Text] [Related]
18. New Perspectives on Ebola Virus Evolution. Brown CJ; Quates CJ; Mirabzadeh CA; Miller CR; Wichman HA; Miura TA; Ytreberg FM PLoS One; 2016; 11(8):e0160410. PubMed ID: 27479005 [TBL] [Abstract][Full Text] [Related]
19. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Wilson JA; Bray M; Bakken R; Hart MK Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406 [TBL] [Abstract][Full Text] [Related]